Inventor · disambiguated record
Philippe Letellier
Also filed as: LETELLIER PHILIPPE
15 granted patents·9 pending applications·107 citations·filing 1983–2019
89Inventor score
Files withSERVIER LAB9PHARMACYCLICS LLC3LETELLIER PHILIPPE2THOMSON LICENSING2INST NAT RECH INF AUTOMAT1
Top patents by PatentIndex Score
24 records- 0191US4546383AMethod and apparatus for visual telecommunications, in particular for use by the deafINST NAT RECH INF AUTOMAT·Filed 1983·Granted Oct 8, 1985·81 cites·19 claims
- 0269US10150748B2Salt or abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing themPHARMACYCLICS LLC·Filed 2017·Granted Dec 11, 2018·1 cites·17 claims
- 0368US7770187B2Applications manager with variable management instruction setTHOMSON LICENSING·Filed 2005·Granted Aug 3, 2010·2 cites·11 claims
- 0467US9115108B2Salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2014·Granted Aug 25, 2015·1 cites·13 claims
- 0566US8710101B2Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing themLETELLIER PHILIPPE·Filed 2012·Granted Apr 29, 2014·2 cites·19 claims
- 0664US9925195B2Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing ISERVIER LAB·Filed 2014·Granted Mar 27, 2018·1 cites·9 claims
- 0763US10898461B2Salts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carboxamide, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the samePHARMACYCLICS LLC·Filed 2019·Granted Jan 26, 2021·0 cites·4 claims
- 0857US8601132B2Reception of audio-visual content addressed to several devicesLETELLIER PHILIPPE·Filed 2006·Granted Dec 3, 2013·2 cites·11 claims
- 0952US8952179B2Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing itSERVIER LAB·Filed 2013·Granted Feb 10, 2015·0 cites·16 claims
- 1051US6543050B1Method and apparatus for enlarging DVB-CI functionality by enabling a direct access to the conditional access moduleTHOMSON LICENSING SA·Filed 1999·Granted Apr 1, 2003·17 cites·10 claims
- 1150US9663451B2Forms of co-crystals of agomelatine and p toluenesulphonic acid, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2014·Granted May 30, 2017·0 cites·8 claims
- 1250US7774800B2Applications manager with variable management instruction setTHOMSON LICENSING·Filed 2005·Granted Aug 10, 2010·0 cites·11 claims
- 1350US2014155453A1SYNTHESIS PROCESS, AND CRYSTALLINE FORM OF 4-{3[CIS-HEXAHYDROCYCLOPENT A[CjPYRROL-2( 1 H)-YLjPROPOXYj BENZAMI DE HYDROCHLORI DE AND PHARMACEUTICAL COMPOSITIONS CONTAINING ITSERVIER LAB·Filed 2014·Application pending·0 cites
- 1449US9573891B2Complexes of agomelatine and sulphonic acids, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2014·Granted Feb 21, 2017·0 cites·14 claims
- 1548US10245270B2Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing itSERVIER LAB·Filed 2018·Granted Apr 2, 2019·0 cites·8 claims
- 1645US8664408B2Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]proxy}benzamide hydrochloride and pharmaceutical compositions containing itROBERT NICOLAS·Filed 2012·Granted Mar 4, 2014·0 cites·12 claims
- 1742US2005149446A1Process for distributing audiovisual documents using fixed downloading facilities and portable terminals, terminals and facilities for the implementation of the processFiled 2003·Application pending·0 cites
- 1842US2004093273A1System and method for the secure distribution of digital content in a sharing networkFiled 2001·Application pending·0 cites
- 1942US2018207171A1Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing itSERVIER LAB·Filed 2018·Application pending·0 cites
- 2042US2004049681A1Time stamping and time stamp validity verification system, method and device in a digital broadcasting environmentFiled 2001·Application pending·0 cites
- 2142US2015315167A1New salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing themPHARMACYCLICS INC·Filed 2015·Application pending·0 cites
- 2242US2005071884A1Module and process for inter-user communicationFiled 2002·Application pending·0 cites
- 2337US2017266151A1Novel salts of 3-[(DIMETHYLAMINO)METHYL]-N--1-BENZOFURAN-2-CARBOXAMIDE, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the samePHARMACYCLICS LLC·Filed 2015·Application pending·0 cites
- 2436US2015238614A1Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing itSERVIER LAB·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philippe Letellier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →